ProfileGDS4718 / 214206_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 55% 46% 62% 54% 47% 53% 63% 54% 56% 54% 50% 51% 53% 53% 50% 56% 49% 51% 58% 66% 50% 53% 54% 53% 48% 48% 52% 54% 51% 50% 46% 59% 56% 46% 49% 54% 59% 56% 46% 52% 54% 43% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3602947
GSM549102patient 115, normal, homogenized [OPG study]5.858655
GSM549104patient 119, normal, homogenized [OPG study]5.2959546
GSM549108patient 138, normal, homogenized [OPG study]6.2841162
GSM549119patient 077, normal, homogenized [OPG study]5.7717754
GSM549133patient 032, cancer, homogenized [OPG study]5.300547
GSM549139patient 042, cancer, homogenized [OPG study]5.6510853
GSM549099patient 107, normal, homogenized [OPG study]6.3272463
GSM549109patient 139, normal, homogenized [OPG study]5.7858954
GSM549110patient 046, normal, homogenized [OPG study]5.8824556
GSM549114patient 063, normal, homogenized [OPG study]5.7084354
GSM549122patient 082, normal, homogenized [OPG study]5.5162250
GSM549134patient 033, cancer, homogenized [OPG study]5.5673951
GSM549136patient 036, cancer, homogenized [OPG study]5.6167953
GSM549140patient 044, cancer, homogenized [OPG study]5.656953
GSM549111patient 047, normal, homogenized [OPG study]5.5129750
GSM549113patient 057, normal, homogenized [OPG study]5.8436956
GSM549132patient 031, cancer, homogenized [OPG study]5.4355249
GSM549137patient 038, cancer, homogenized [OPG study]5.5372551
GSM549142patient 047, cancer, homogenized [OPG study]6.1166858
GSM549100patient 110, normal, homogenized [OPG study]6.5369166
GSM549107patient 135, normal, homogenized [OPG study]5.4887750
GSM549115patient 068, normal, homogenized [OPG study]5.6332353
GSM549116patient 072, normal, homogenized [OPG study]5.7533554
GSM549120patient 078, normal, homogenized [OPG study]5.6512153
GSM549131patient 030, cancer, homogenized [OPG study]5.3758448
GSM549118patient 074, normal, homogenized [OPG study]5.4007348
GSM549129patient 027, cancer, homogenized [OPG study]5.6524552
GSM549123patient 088, normal, homogenized [OPG study]5.7254154
GSM549124patient 006, cancer, homogenized [OPG study]5.6194151
GSM549126patient 015, cancer, homogenized [OPG study]5.4838250
GSM549128patient 025, cancer, homogenized [OPG study]5.2908546
GSM549103patient 117, normal, homogenized [OPG study]6.0906559
GSM549117patient 073, normal, homogenized [OPG study]5.8357156
GSM549138patient 041, cancer, homogenized [OPG study]5.2700846
GSM549141patient 045, cancer, homogenized [OPG study]5.4031549
GSM549130patient 028, cancer, homogenized [OPG study]5.7640954
GSM549101patient 111, normal, homogenized [OPG study]6.0841159
GSM549105patient 128, normal, homogenized [OPG study]5.8602556
GSM549106patient 134, normal, homogenized [OPG study]5.267346
GSM549112patient 048, normal, homogenized [OPG study]5.6411452
GSM549125patient 011, cancer, homogenized [OPG study]5.7256254
GSM549127patient 024, cancer, homogenized [OPG study]5.1605943
GSM549135patient 035, cancer, homogenized [OPG study]5.5389851